Clofazimine: A potential therapeutic option for severe COVID-19.

Med Hypotheses

Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; Institut für Klinische Pharmakologie und Toxikologie, Charité-Universitätsmedizin, Berlin, Germany. Electronic address:

Published: May 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880843PMC
http://dx.doi.org/10.1016/j.mehy.2021.110535DOI Listing

Publication Analysis

Top Keywords

clofazimine potential
4
potential therapeutic
4
therapeutic option
4
option severe
4
severe covid-19
4
clofazimine
1
therapeutic
1
option
1
severe
1
covid-19
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!